“Ryan is a driven, organized, and passionate leader. He collaborates well with peers, takes ownership and accountability, and persists to see actions through to resolution. Ryan was a great colleague with whom to partner! ”
About
Dynamic drug development leader with 25 years experience in the pharma, biotech, and CRO…
Activity
-
The first patient with advanced #NSCLC with a tumor that has activating HER2 mutations has been enrolled in the phase 3 SOHO-02 trial of frontline…
The first patient with advanced #NSCLC with a tumor that has activating HER2 mutations has been enrolled in the phase 3 SOHO-02 trial of frontline…
Liked by Ryan Hardy
-
Novavax has received Emergency Use Authorization from the U.S. #FDA for its updated COVID-19 vaccine. Pre-filled syringes are expected to be…
Novavax has received Emergency Use Authorization from the U.S. #FDA for its updated COVID-19 vaccine. Pre-filled syringes are expected to be…
Liked by Ryan Hardy
-
SLU's 2024 Welcome Week was nothing short of amazing. Here’s to a fantastic year ahead! 🎉
SLU's 2024 Welcome Week was nothing short of amazing. Here’s to a fantastic year ahead! 🎉
Liked by Ryan Hardy
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
-
-
Volunteer Experience
-
Baseball Coach
Lee's Summit Baseball Association
Children
-
-
-
-
-
-
-
Elementary School Watch Dog (anti-bullying volunteer)
Watch D.O.G.S. (Dads of Great Students)
Children
Languages
-
English
-
-
Spanish
-
Recommendations received
14 people have recommended Ryan
Join now to viewMore activity by Ryan
-
🚀 Just wrapped up an inspiring visit to the Peter MacCallum Cancer Centre in Melbourne! The collaboration between Syneos Health and Peter Mac is set…
🚀 Just wrapped up an inspiring visit to the Peter MacCallum Cancer Centre in Melbourne! The collaboration between Syneos Health and Peter Mac is set…
Liked by Ryan Hardy
-
Pleased to share that the European Commission has granted Marketing Authorization to our partner, Astellas Pharma, for our antibody drug conjugate in…
Pleased to share that the European Commission has granted Marketing Authorization to our partner, Astellas Pharma, for our antibody drug conjugate in…
Liked by Ryan Hardy
-
As Daiichi Sankyo US Global Team Lead, Oncology R&D, Dalila Sellami has seen firsthand the impact a new medicine can have on a patient and their…
As Daiichi Sankyo US Global Team Lead, Oncology R&D, Dalila Sellami has seen firsthand the impact a new medicine can have on a patient and their…
Liked by Ryan Hardy
-
BREAKING: The combination of lazertinib and amivantamab is now FDA-approved for the first-line treatment of adult patients with locally advanced or…
BREAKING: The combination of lazertinib and amivantamab is now FDA-approved for the first-line treatment of adult patients with locally advanced or…
Liked by Ryan Hardy
-
The FDA approved Pfizer and BioNTech SE’s updated COVID-19 vaccine for the upcoming US 2024-2025 fall and winter season. Recommended for those aged 6…
The FDA approved Pfizer and BioNTech SE’s updated COVID-19 vaccine for the upcoming US 2024-2025 fall and winter season. Recommended for those aged 6…
Liked by Ryan Hardy
-
Nothing beats the joy and emotion of the first day of classes at SLU. We're wishing our Billikens the best of luck this school year! 📚 📸 by Sarah…
Nothing beats the joy and emotion of the first day of classes at SLU. We're wishing our Billikens the best of luck this school year! 📚 📸 by Sarah…
Liked by Ryan Hardy
-
🚀 BioNTech Leads the Way in Global Vaccine Justice German biotech pioneer BioNTech SE is making history by establishing Africa’s first modular mRNA…
🚀 BioNTech Leads the Way in Global Vaccine Justice German biotech pioneer BioNTech SE is making history by establishing Africa’s first modular mRNA…
Liked by Ryan Hardy
-
The #FDA accepted the supplemental biologics license application for nivolumab + ipilimumab in the first line for patients with unresectable…
The #FDA accepted the supplemental biologics license application for nivolumab + ipilimumab in the first line for patients with unresectable…
Liked by Ryan Hardy
-
I’m thrilled to share another U.S. FDA approval in lung cancer this year, which marks another significant breakthrough for patients and their…
I’m thrilled to share another U.S. FDA approval in lung cancer this year, which marks another significant breakthrough for patients and their…
Liked by Ryan Hardy
-
BREAKING: The FDA has approved #amivantamab-vmjw (#Rybrevant) in combination with #lazertinib (#Lazcluze) for the first-line treatment of adult…
BREAKING: The FDA has approved #amivantamab-vmjw (#Rybrevant) in combination with #lazertinib (#Lazcluze) for the first-line treatment of adult…
Liked by Ryan Hardy
-
Exciting news in colorectal cancer treatment - Harpreet Singh, MD FDA Precision For Medicine https://lnkd.in/djKct2pv #Cancer #CRCSM…
Exciting news in colorectal cancer treatment - Harpreet Singh, MD FDA Precision For Medicine https://lnkd.in/djKct2pv #Cancer #CRCSM…
Liked by Ryan Hardy
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Ryan Hardy in United States
169 others named Ryan Hardy in United States are on LinkedIn
See others named Ryan Hardy